(Difference between revisions)
|
|
| Line 59: |
Line 59: |
| | | | |
| | ==Links== | | ==Links== |
| − | {{wiki|en=Riociguat|de=Riociguat|c=|}} | + | {{slink|l=http://www.heise.de/tr/artikel/Das-war-elektrisierend-2854064.html |t=Heise-Technol-Rev. Bericht zur Ehrung der Entwickler |c= }} |
| | + | {{wiki|en=Riociguat|de=Riociguat|c=|}} |
| | | | |
| | ==Books== | | ==Books== |
| | | | |
Revision as of 16:30, 26 October 2015
Core OA papers on Riociguat
| Journal article, free access
|
| GET 2014. Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Riociguat: Something new in pulmonary hypertension therapeutics? Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Riociguat for the treatment of pulmonary arterial hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2010. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2014. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension Extract PDF direct
|
General outline of Pulmonary Hypertension
| Journal article, free access
|
| GET 2013. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Medical treatment update on pulmonary arterial hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2015. The molecular targets of approved treatments for pulmonary arterial hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Drug Therapy for Chronic Thromboembolic Pulmonary Hypertension: A Review of the Comparative Clinical Effectiveness Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Respiratory review of 2014: pulmonary thromboembolism Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Novel and emerging therapies for pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Chronic thromboembolic pulmonary hypertension: role of medical therapy Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2015. Pulmonary arterial hypertension: a review in pharmacotherapy Extract PDF direct
|
Mechanism of action
| Journal article, free access
|
| GET 2010. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? Extract PDF direct
|
| Journal article, free access
|
| GET 2009. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy Extract PDF direct
|
| Journal article, free access
|
| GET 2008. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2013. The chemistry and biology of soluble guanylate cyclase stimulators and activators Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2009. Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2013. Soluble guanylate cyclase stimulators in pulmonary hypertension Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2009. NO-independent, haem-dependent soluble guanylate cyclase stimulators Extract [{| class="wikitable"; style="border: 1pt"
|
| Journal Paper, restricted access
|
| GET 2013. Soluble guanylate cyclase stimulators in pulmonary hypertension Extract PDF direct
|
PDF direct]
|}
Some trials
| Journal Paper, restricted access
|
| GET 2015. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2015. Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2) Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study Extract PDF direct
|
| Journal article, free access
|
| GET 2014. Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Treatment of pulmonary hypertension caused by left heart failure with pulmonary arterial hypertension-specific therapies: lessons from the right and LEPHT Extract PDF direct
|
| Journal article, free access
|
| GET 2013. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study Extract PDF direct
|
Nephrology-related data
| Journal Paper, restricted access
|
| GET 2015. Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies Extract PDF direct
|
| Journal article, free access
|
| GET 2015. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence Extract PDF direct
|
| Journal article, free access
|
| GET 2011. Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats Extract PDF direct
|
| Journal Paper, restricted access
|
| GET 2010. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models Extract PDF direct
|
Links
Books
